Delayed diagnosis and fragmented care remain persistent challenges across women's health, due in part to limitations in evaluating the dynamic female hormone profile. Current clinical approaches to hormonal assessment often rely on single timepoint assessments that fail to capture hormonal variability, leading to incomplete or misleading insight into hormonal health. Recent technological advancements now allow for quantitative measurement of key reproductive hormones in urine using smartphone-compatible, at-home devices, making daily hormone monitoring across the menstrual cycle and reproductive lifespan feasible. The purpose of this illustrative, case-based perspective is to provide insight into: 1) when and why comprehensive at-home, daily hormone monitoring could be implemented; 2) how comprehensive hormone monitoring gives insight into the health state of women at different reproductive stages; and 3) how such information can inform lifestyle or medical recommendations. Illustrative case-based examples are given to demonstrate the potential applications of comprehensive at-home, daily hormone monitoring across the reproductive lifespan, including low energy availability (LEA), postpartum return to exercise, polyendocrine metabolic ovarian syndrome (PMOS), and perimenopause. Across cases, daily monitoring of reproductive hormones revealed hormone patterns that were not identifiable using traditional methods. In many cases, clinically meaningful patterns of ovulatory function, luteal phase quality, or reproductive stage were identified within one to two cycles, allowing more individualized lifestyle or medical interventions to be implemented. Collectively, these illustrative cases demonstrate that, when integrated with comprehensive clinical assessment and practitioner expertise, daily hormone monitoring can provide actionable insight into female physiology, support earlier identification of hormonal dysregulation, and inform personalized medicine and lifestyle changes across the reproductive lifespan.